Clinical Trials Directory

Trials / Unknown

UnknownNCT04764981

Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)

Clinical Outcomes of Olfactory Training for Treatment of Olfactory Dysfunction After COVID-19

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
Universidade do Estado do Pará · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

It is a randomized controlled clinical trial study that aims to follow a sample of individuals with persistent olfactory dysfunction post-COVID-19. The aim of this study is assess the clinical outcomes of olfactory training therapy in the treatment of persistent olfactory dysfunctions after COVID-19. The sample will consist of 350 participants, being 300 individuals with persistent olfactory dysfunction post-COVID-19 and 50 healthy individuals. Volunteers' will be separated in two experimental groups (1 and 2 ) and a control group. All participants will be submitted to clinical evaluation that include the Connecticut Chemosensory Clinical Research Test (CCCRT), an olfactory test to diagnose anosmia and hyposmia, and two skull Magnetic Resonance imaging (MRI). Only participants of Experimental group 1 will be submitted to an olfactory training with essences oils. Experimental group 2 will only receive a clinical follow-up after three months and control group will be only submitted to neurological exam, olfactory test, MRI imaging and test their ability to discriminate the essence oils used in olfactory training. As a result, is expected a better understanding of the characteristics of olfactory dysfunction caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus infection, as well as the effectiveness and viability of using Olfactory Training as a therapeutic alternative.

Conditions

Interventions

TypeNameDescription
OTHEREssence oilsConsists in olfactory training using essence oils

Timeline

Start date
2021-05-01
Primary completion
2022-05-01
Completion
2024-05-01
First posted
2021-02-21
Last updated
2021-02-21

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04764981. Inclusion in this directory is not an endorsement.